series-a
Stage
2021
Founded
1
Investors
About
Vesalius Therapeutics is a biotechnology company focused on precision drug development for common diseases such as heart failure, type II diabetes, Alzheimer’s disease, and obesity using AI, machine learning, and genomics.
Explore Vesalius Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.